Table 2 Univariable analysis of disease-free and overall survival in gastric cancer

Age(y)

.343

.583

< 60

95

1.00

1.00

≥60

86

0.834

0.573-1.214

0.898

0.611-1.320

Sex

.662

.950

Male

129

1.00

1.00

Female

52

0.909

0.591-1.396

0.986

0.639-1.521

Tumor size

.151

.232

≤4 cm

63

1.00

1.00

> 4 cm

118

1.345

0.897-2.016

1.287

0.851-1.945

pT stage

.001

.005

pT1

17

1.00

1.00

pT2

35

1.549

0.558-4.301

.401

1.535

0.553-4.264

.411

pT3

119

3.546

1.437-8.750

.006

3.237

1.310-8.001

.011

pT4

10

4.738

1.547-14.506

.006

4.068

1.289-12.836

.017

pN stage

< .0001

.001

Negative

44

1.00

1.00

Positive

137

2.617

1.538-4.451

2.389

1.401-4.075

pTNM stage

< .0001

.001

I

26

1.00

1.00

II

47

2.920

1.197-7.121

.018

2.860

1.173-6.973

.021

III

100

4.955

2.152-11.409

< .0001

4.455

1.930-10.281

< .0001

IV

8

7.369

2.470-21.981

< .0001

6.103

1.965-18.957

.002

p-mTOR

.008

.013

Negative

88

1.00

1.00

Positive

93

1.667

1.146-2.454

1.644

1.112-2.430